Epivax is a biotechnology company based in Providence, RI, specializing in the development of novel vaccines and immunotherapies.
With a focus on leveraging computational tools and bioinformatics, Epivax aims to advance research in the fields of infectious diseases and autoimmune disorders.
Generated from their business information